Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190968 | 0.94 | GABRA1 (0.52) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL28241863 | 0.91 | GABRA1 (0.50) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL31071024 | 0.86 | RXRB (0.41) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL18537286 | 0.84 | GABRA1 (0.44) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL34460149 | 0.84 | POLB (0.41) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL23915436 | 0.84 | GABRA1 (0.44) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL29416703 | 0.84 | GABRA1 (0.44) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL2745570 | 0.84 | POLB (0.41) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL25361919 | 0.82 | GABRA1 (0.37) | GABRA1GABRB2POLBHIF1ACYP2C19 | |
| SCHEMBL1104681 | 0.82 | NOTUM (0.47) | GABRA1GABRB2POLBMAPTNOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119100974-A | Conductive two-dimensional supermolecular polymer constructed based on aromatic ring cation-pi action and preparation method thereof | 西北工业大学 | 2024-12-10 | — | — | CN | claimed |
| CN-119092798-A | MOF-based solid electrolyte composite membrane and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2024-12-06 | — | — | CN | claimed |
| CN-118219636-B | Polymer self-adhesive pre-laid waterproof coiled material and preparation method thereof | 丽天防水科技有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-118219636-A | Polymer self-adhesive pre-laid waterproof coiled material and preparation method thereof | 丽天防水科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117143348-A | Metal-MOF composite material and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2023-12-01 | — | — | CN | claimed |
| CN-116554378-A | Non-metallocene catalyst, preparation method and application | 万华化学集团股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-108358795-A | One kind is containing tertiary butyl substitution m-Terphenyl structure aromatic diamine monomers and preparation method thereof | 常州大学 | 2018-08-03 | — | — | CN | claimed |
| US-20260150575-A1 | LIGHT-EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR LIGHT-EMITTING ELEMENT, AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| EP-4742867-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS | Samsung Electronics Co., Ltd. (KR) | 2026-05-13 | — | — | EP | disclosed |
| US-20260123177-A1 | POLYCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE POLYCYCLIC COMPOUND, ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-30 | — | — | US | disclosed |
| US-12598908-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4436349-B1 | LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND | SAMSUNG DISPLAY CO LTD (KR) | 2026-04-01 | — | — | EP | disclosed |
| EP-4714959-A1 | LIGHT EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2026-03-25 | — | — | EP | disclosed |
| WO-2009042694-A1 | (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING | COMENTIS, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009015369-A2 | COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF | COMENTIS, INC. (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20080124577-A1 | Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability | CANON KABUSHIKI KAISHA (JP) | 2008-05-29 | — | — | US | disclosed |
| WO-2007064553-A2 | THIAZOLE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| US-7214668-B2 | Phosphonic acid based prodrugs of PMEA and its analogues | METABASIS THERAPEUTICS, INC. (US) | 2007-05-08 | — | — | US | disclosed |
| US-20060115678-A1 | Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2006-06-01 | — | — | US | disclosed |
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260150575-A1 | LIGHT-EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR LIGHT-EMITTING ELEMENT, AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING ELEMENT | NR2E3, NR2E1, RER1 | GABRA1 2644/4885GABRB2 2701/4885POLB 3785/4885 |
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ADORA2A, ADORA1, PDE2A | GABRA1 500/4885GABRB2 386/4885POLB 4166/4885 |
| US-12598908-B2 | Organic electroluminescent materials and devices | LBR, OPRD1, LDLR | GABRA1 1014/4885GABRB2 929/4885POLB 1215/4885 |
| US-20080124577-A1 | Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability | LEF1, MAP1LC3A, HSF1 | GABRA1 4392/4885GABRB2 4690/4885POLB 4144/4885 |
| US-20060115678-A1 | Aminoanthryl derivative-substituted pyrene compound and organic light-emitting device | ALAD, PAH, PPOX | GABRA1 2220/4885GABRB2 3557/4885POLB 1683/4885 |
| US-20260123177-A1 | POLYCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE POLYCYCLIC COMPOUND, ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | CDH1, CRY2, CRY1 | GABRA1 3178/4885GABRB2 2357/4885POLB 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.